[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342564-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342564-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pan-cancer-analysis-of-pgam1-and-its-experimental-validation-in-uveal-melanoma-progression","Pan-Cancer Analysis of PGAM1 and Its Experimental Validation in Uveal Melanoma Progression","","Phosphoglycerate mutase 1 (PGAM1) regulates cancer glycolysis, but its expression and function in uveal melanoma (UVM) were unclear. The study analyzed PGAM1 across 33 cancer types using public databases, finding aberrant overexpression linked to poor prognosis, advanced staging, and aggressive phenotypes, including in UVM. PGAM1 correlated with tumor-promoting immune infiltration. Cell and tissue experiments confirmed UVM upregulation, and PGAM1 knockdown reduced migration, invasion, and promoted apoptosis with PD-L1, Snail, and Bcl-2 decreases and E-cadherin increases, suggesting PGAM1 as a prognostic biomarker and therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pan-cancer-analysis-of-pgam1-and-its-experimental-validation-in-uveal-melanoma-progression/342564/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-of-pgam1-and-its-experimental-validation-in-uveal-melanoma-progression/342564.png","ImageObject",300,407,{"name":42,"@type":43},"Anda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of this study on PGAM1 in uveal melanoma?","Question",{"text":63,"@type":64},"To determine whether PGAM1 expression and function are relevant to uveal melanoma progression and whether PGAM1 could serve as a prognostic biomarker and therapeutic target.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What did the pan-cancer database analysis show about PGAM1?",{"text":68,"@type":64},"PGAM1 was aberrantly overexpressed in most tumors compared with normal tissues, and the overexpression associated with poor prognosis, advanced staging, and aggressive clinical phenotypes, including in UVM.",{"name":70,"@type":61,"acceptedAnswer":71},"How did PGAM1 knockdown affect uveal melanoma cells?",{"text":72,"@type":64},"Knockdown inhibited migration and invasion and induced apoptosis, accompanied by reduced PD-L1, Snail, and BCl-2 and increased E-cadherin.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342564,1790195314,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Ivyspring  \nInternational Publisher  \nJournal of Cancer  \n2024; 15(7): 2074-2094. doi: 10.7150/jca.93398  \nResearch Paper  \nPan-Cancer Analysis of PGAM1 and Its Experimental Validation in Uveal Melanoma Progression  \nWeihong Niu1,3, Yan Yang2, Yuetai Teng6, Na Zhang5􀀍, Xu Li4􀀍, Yinhui Qin2􀀍  \n1. Department of Pathology, Henan Key Laboratory for Digital Pathology Medicine, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou 450003, Henan, China.  \n2. Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou 450003, Henan, China.  \n3. Microbiome Laboratory, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou 450003, Henan, China.  \n4. Institute of Chemistry Henan Academy of Sciences, No. 56 Hongzhuan Road, Jinshui District, Zhengzhou 450002, China.  \n5. Shandong Academy of Chinese Medicine, Jinan 250014, China.  \n6. Department of Pharmacy, Jinan Vocational College of Nursing, Jinan 250102, China.  \n􀀍 Corresponding authors: Yinhui Qin, Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou 450003, Henan, China, E-mail: [qyhcpu@163.com. Xu Li](qyhcpu@163.com. Xu Li), Institute of Chemistry Henan Academy of Sciences, No. 56 Hongzhuan Road, Jinshui District, Zhengzhou 450002, China, E-mail: [lixu8928753@163.com. Na Zhang](lixu8928753@163.com. Na Zhang), Shandong Academy of Chinese Medicine, Jinan 250014, China, E-mail: [17862924548@163.com](17862924548@163.com).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [http://ivyspring.com/terms](http://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2023.12.20; Accepted: 2024.01.30; Published: 2024.02.17  \nAbstract  \nPhosphoglycerate mutase 1 (PGAM1) is a key enzyme regulating cancer glycolysis. However, the expression and function of PGAM1 in uveal melanoma (UVM) are unknown and systematic analysis is lacking. This study performed a comprehensive analysis of PGAM1 expression across 33 cancer types in multiple public databases. Results demonstrated PGAM1 is aberrantly overexpressed in most tumors compared to normal tissues, and this overexpression is associated with poor prognosis, advanced tumor staging, and aggressive clinical phenotypes in multiple cancers including UVM, lung, breast and bladder carcinomas. In addition, PGAM1 expression positively correlated with infiltration levels of tumor-promoting immune cells including macrophages, NK cells, myeloid dendritic cells, etc. Further experiments showed that PGAM1 was overexpressed in UVM cell lines and tissues, and it was positively associated with a poor prognosis of UVM patients. And knockdown of PGAM1 inhibited migration/invasion and induced apoptosis in UVM cells, followed by decreased levels of PD-L1, Snail, and BCl-2 and increased levels of E-cadherin. Additionally, the correlation analysis and molecular docking results suggest that PGAM1 could interact with PD-L1, Snail and BCl-2. Thus, PGAM1 may promote UVMpathogenesis via modulating immune checkpoint signaling, EMT and apoptosis. Collectively, this study reveals PGAM1 as a valuable prognostic biomarker and potential therapeutic target in aggressive cancers including UVM.  \nKeywords: PGAM1; UVM; Immune infiltration; EMT; Apoptosis  \nIntroduction  \nCancer is a major global health challenge and the leading cause of mortality worldwide, resulting in approximately 10 million deaths in 2020 alone [1, 2] . Among the various types of cancer, UVM is a rare but aggressive form of intraocular malignancy that originates from melanocytes within the uveal tract, comprising the iris, ciliary bo","cbCaiekUEHe670JG","https://ap.wps.com/l/cbCaiekUEHe670JG","pdf",13387521,21,"English","# Abstract\n# Introduction\n## Uveal melanoma burden and unmet needs\n## PGAM1 in glycolysis and cancer biology\n## Study objective and rationale","[{\"question\":\"What was the purpose of this study on PGAM1 in uveal melanoma?\",\"answer\":\"To determine whether PGAM1 expression and function are relevant to uveal melanoma progression and whether PGAM1 could serve as a prognostic biomarker and therapeutic target.\"},{\"question\":\"What did the pan-cancer database analysis show about PGAM1?\",\"answer\":\"PGAM1 was aberrantly overexpressed in most tumors compared with normal tissues, and the overexpression associated with poor prognosis, advanced staging, and aggressive clinical phenotypes, including in UVM.\"},{\"question\":\"How did PGAM1 knockdown affect uveal melanoma cells?\",\"answer\":\"Knockdown inhibited migration and invasion and induced apoptosis, accompanied by reduced PD-L1, Snail, and BCl-2 and increased E-cadherin.\"}]","Pan-Cancer Analysis of PGAM1 and Its Experimental Validation in Uveal Melanoma Progression | PDF",1790047171,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90f3b65460901c2d8035a8e51b749026.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d1d22d1c9c297542f6ccc8a4873f233.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c292986a07ea962a0523d17f15ce1995.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20b7d3d32f0b0a016b7a7b7a42a92b30.webp",980,1268]